| 000 | 01223nam a22001337a 4500 | ||
|---|---|---|---|
| 020 | _a978-1-78536-938-4 | ||
| 082 |
_a615.45:346.58.061 _bYU |
||
| 100 | _aYu, Helen | ||
| 245 | _aAchieving Proof of Concept in Drug Discovery and Development | ||
| 260 |
_aUK _bEdward Elgar _c2016 |
||
| 300 | _axiv,266p. | ||
| 650 |
_aPART I LANDSCAPE OF DRUG DISCOVERY AND DEVELOPMENT _a1. Introduction _a2. The pharmaceutical industry and drug discovery and development models _a3. Intellectual property rights and competition law in collaborative drug discovery and development between industry and integrated drug discovery organizations _aPART II. ANALYSIS AND APPLICATION OF EU COMPETITION LAW TO THE INTEGRATED DRUG DISCOVERY AND DEVELOPMENT MODEL _a4. Application of competition law to the integrated drug discovery and development model: research and development block exemption regulation _a5. Application of competition law to the integrated drug discovery and development model: technology transfer block exemption regulation _aPART III. CASE STUDY: AGREEMENTS BETWEEN INDUSTRY AND INTEGRATED DRUG DISCOVERY ORGANIZATIONS _a6. Analysis of collaboration agreements between integrated drug discovery organizations and industry |
||
| 942 | _cBK | ||
| 999 |
_c348147 _d348147 |
||